Wells Fargo Downgrades St. Jude Medical (STJ) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
FDA Voices Concern Over St. Jude (STJ) Durata Lead Testing; Shares Fall
November 21, 2012 12:15 PM ESTSt. Jude (NYSE: STJ) is getting hit Wednesday following criticism from the FDA over the company's Durata defibrillator leads.
The FDA said that St. Jude failed to follow proper inspection procedures at its Irvine, California-based facility. The FDA inspection was date from September... More
